Capital efficiency slipping
ROCE has fallen for 3 consecutive years, from 52.7% to 35.5%.
Importance 59 / 95 · profitability
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
ROCE has fallen for 3 consecutive years, from 52.7% to 35.5%.
Importance 59 / 95 · profitability
ROE of 27.1% is well above the speciality retail median of 16.4%.
Importance 53 / 95 · profitability
EBITDA margin of 18.9% is the widest in 4 years (prior range 16.2% to 17.9%).
Importance 52 / 95 · profitability
Classified by the exchange under Consumer Discretionary › Consumer Services › Retailing › Speciality Retail.
Peer set used on this page: 2 speciality retail.
Revenue grew 360% a year over 4 years, from ₹45 cr in FY2022 to ₹20,074 cr in FY2026. Net profit grew 63.5% a year over 3 years (FY2023–FY2026).
Net profit grew 12.2% year on year (FY2025 → FY2026).
Rule PROFIT_GREW_YOY
Revenue grew 17.2% year on year (FY2025 → FY2026).
In Q2 FY27 (Jul–Sep 2026), revenue was ₹5,873 cr (up 21.9% on the same quarter last year) and net profit ₹468 cr (up 25.4%).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q2 FY27 net profit was ₹468 cr, up 25.4% from ₹373 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q2 FY27 revenue was ₹5,873 cr, up 21.9% from ₹4,818 cr in Q2 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Q2 FY27 EBIT was ₹684 cr, up 31.7% from ₹520 cr a year earlier.
Rule QTR_OPERATING_PERFORMANCE_CHANGE_YOY
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q3 FY25 | 4,657 | +34.3% | 497 | +34.0% | 10.7% |
| Q4 FY25 | 4,217 | +27.9% | 312 | −56.2% | 7.4% |
| Q1 FY26 | 4,883 | +19.0% | 425 | +8.6% | 8.7% |
| Q2 FY26 | 4,818 | +15.9% | 373 | +11.4% | 7.8% |
| Q3 FY26 | 5,345 | +14.8% | 510 | +2.7% | 9.5% |
| Q4 FY26 | 5,028 | +19.2% | 413 | +32.6% | 8.2% |
| Q1 FY27 | 5,755 | +17.8% | 518 | +22.0% | 9.0% |
| Q2 FY27 | 5,873 | +21.9% | 468 | +25.4% | 8.0% |
Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters
EBITDA margin was 18.9% in FY2026, against 16.7% in FY2022. ROE was 27.1% and ROCE 35.5% in FY2026.
ROCE has fallen for 3 consecutive years, from 52.7% to 35.5%.
Rule ROCE_DECLINING_STREAK
ROE of 27.1% is well above the speciality retail median of 16.4%.
EBITDA margin of 18.9% is the widest in 4 years (prior range 16.2% to 17.9%).
ROE declined from 31.7% to 27.1% year on year.
Debt-to-equity was 0.07x in FY2026, against 0.21x in FY2022; interest coverage 14.42x. Operating cash flow was 1.55x net profit.
Free cash flow has been positive in 4 of the last 5 years.
Rule FCF_CONSISTENTLY_POSITIVE
Its peer group is too small for a meaningful ranking.
Ranked against 2 speciality retail (FY2026, consolidated).
Not enough peers in this set report the underlying metrics yet for a ranking.
Trades at 60.55× earnings — 46% below the speciality retail median of 111.35×.
Rule PE_BELOW_PEERS
On the trailing twelve months. Last full year: P/E 67.2× · P/S 5.7× · ROE 27.1%.
The share price is up 11.2% over 1 year, up 86.6% over 3 years (23.1% a year) and up 329% over 5 years (33.8% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is 2.7% below its 52-week high.
Over 3 years profit compounded at 63.5% a year while the stock returned 23.1% a year — but FY2023 profit (₹394) was well below the through-cycle level (~₹1,506), so this rate is inflated by the recovery from a low base.
Rule STOCK_LAGGED_EARNINGS · recovery
Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 45 | 8,242 | 12,375 | 17,135 | 20,074 |
| Total income | 47 | 8,503 | 12,664 | 17,353 | 20,189 |
| EBITDA | 7 | 1,335 | 2,211 | 2,977 | 3,788 |
| Profit before tax | 1 | 469 | 1,797 | 1,943 | 2,233 |
| Net profit | — | 394 | 1,477 | 1,534 | 1,721 |
| EPS (₹) | 1.0 | 12.5 | 41.8 | 43.5 | 48.4 |
| Net worth | 24 | 2,663 | 4,103 | 5,583 | 7,108 |
| Total debt | 5 | 498 | 499 | 499 | 500 |
| Operating cash flow | — | 595 | 1,349 | 1,661 | 2,668 |
| Free cash flow | −2 | 371 | 955 | 799 | 931 |
| Ratio | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue growth YoY | — | — | 50.1 | 38.5 | 17.2 |
| Profit growth YoY | — | — | 275.3 | 3.9 | 12.2 |
| Profitability | |||||
| EBITDA margin % | 16.7 | 16.2 | 17.9 | 17.4 | 18.9 |
| Net margin % | — | 4.6 | 11.7 | 8.8 | 8.5 |
| Return on equity % | — | 29.3 | 43.7 | 31.7 | 27.1 |
| Return on capital % | 15.1 | 52.7 | 39.7 | 39.0 | 35.5 |
| Leverage & cash | |||||
| Debt to equity | 0.21 | 0.19 | 0.12 | 0.09 | 0.07 |
| Cash flow ÷ profit | — | 1.51 | 0.91 | 1.08 | 1.55 |
| Current ratio | 2.72 | 2.17 | 2.02 | 1.82 | 1.26 |